Search

Your search keyword '"Kreutz, Reinhold"' showing total 1,576 results

Search Constraints

Start Over You searched for: Author "Kreutz, Reinhold" Remove constraint Author: "Kreutz, Reinhold"
1,576 results on '"Kreutz, Reinhold"'

Search Results

4. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

10. Rivaroxaban vs Vitamin K Antagonist in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease

12. The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)

19. Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review

22. Studies in Zebra Fish and Rat Models Support Dual Blockade of EP2 and EP4 (Prostaglandin E2 Receptors Type 2 and 4) for Renoprotection in Glomerular Hyperfiltration and Albuminuria

28. CHARACTERIZATION OF EARLY FUNCTIONAL, STRUCTURAL AND MOLECULAR ALTERATIONS IN A RAT MODEL OF CARDIORENAL SYNDROME TYPE IV: ROLE OF BMP-2

29. ASSESSMENT AND MANAGEMENT OF PATIENTS WITH OBESITY AND HYPERTENSION IN EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES. A SURVEY FROM THE ESH WORKING GROUP ON DIABETES AND META

30. Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines

36. Laboratory Testing for Endocrine Hypertension: Current and Future Perspectives

38. The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).

39. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension

41. The impact of the COVID-19 Pandemic on hypertension phenotypes (ESH ABPM COVID-19 study)

42. The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study)

43. Rationale of treatment recommendations in the 2023 ESH hypertension guidelines

44. Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?

45. Rationale of treatment recommendations in the 2023 ESH hypertension guidelines

46. Assessment and Management of Patients with Obesity and Hypertension in European Society of Hypertension Excellence Centres. A survey from the ESH Working Group on Diabetes and Metabolic Risk Factors

47. Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension

49. Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group 'Hypertension in Women'.

50. Assessment and management of exaggerated blood pressure response to standing and orthostatic hypertension: consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.

Catalog

Books, media, physical & digital resources